BeOne Medicines (BEIGF) Change in Acquisitions & Divestments (2015 - 2025)

BeOne Medicines (BEIGF) has reported Change in Acquisitions & Divestments for 11 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.6 million in Q4 2025; TTM through Dec 2025 was $3.4 million, a 29.79% increase from a year earlier, with the FY2025 full-year figure at $3.4 million, up 29.79% from the prior year.
• Change in Acquisitions & Divestments was $1.6 million for Q4 2025 at BeOne Medicines, down from $1.8 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $1.1 billion in Q1 2021 and troughed at $19000.0 in Q3 2023.
• A 5-year average of $359.3 million and a median of $301.4 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments jumped 331.17% in 2021 and tumbled 99.99% in 2023, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $388.5 million in 2021, then slumped by 45.63% to $211.2 million in 2022, then tumbled by 49.95% to $105.7 million in 2023, then sank by 97.49% to $2.7 million in 2024, then tumbled by 38.0% to $1.6 million in 2025.
• The last three Change in Acquisitions & Divestments figures came in at $1.6 million (Q4 2025), $1.8 million (Q1 2025), and $2.7 million (Q1 2024), per Business Quant data.